- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1437-7772
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer ; day:17 ; month:1 ; year:2018 ; pages:1-12
International journal of clinical oncology ; (17.1.2018), 1-12
- Keyword
-
Krebs
Onkologie
- Creator
-
Gong, Zhenqiang
- Contributor
-
Ma, Jiachi
Su, He
Guo, Tiankang
Cai, Hui
Chen, Quan
Zhao, Xiaodan
Qi, Jianbo
Du, Jianbo
SpringerLink (Online service)
- DOI
-
10.1007/s10147-018-1242-2
- URN
-
urn:nbn:de:1111-201803195763
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gong, Zhenqiang
- Ma, Jiachi
- Su, He
- Guo, Tiankang
- Cai, Hui
- Chen, Quan
- Zhao, Xiaodan
- Qi, Jianbo
- Du, Jianbo
- SpringerLink (Online service)
Other Objects (12)
CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth
Indirubin derivative E804 inhibits angiogenesis
Interleukin-1-receptor-antagonist inhibits migratory and invasive capacity of bladder cancer cells in vitro
CDK5RAP3 inhibits angiogenesis in gastric neuroendocrine carcinoma by modulating AKT/HIF-1α/VEGFA signaling
Interleukin-1 receptor antagonist inhibits metastatic potential by down-regulating CXCL12/CXCR4 signaling axis in colorectal cancer
Interleukin-1-Rezeptor-Antagonist-Gen-Polymorphismus beim Ovarialkarzinom
Lycorine inhibits angiogenesis by docking to PDGFRα
Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis
COCO/DAND5 inhibits developmental and pathological ocular angiogenesis
SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression
Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury
Production of interleukin-1 receptor antagonist by human articular chondrocytes
CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth
Indirubin derivative E804 inhibits angiogenesis
Interleukin-1-receptor-antagonist inhibits migratory and invasive capacity of bladder cancer cells in vitro
CDK5RAP3 inhibits angiogenesis in gastric neuroendocrine carcinoma by modulating AKT/HIF-1α/VEGFA signaling
Interleukin-1 receptor antagonist inhibits metastatic potential by down-regulating CXCL12/CXCR4 signaling axis in colorectal cancer
Interleukin-1-Rezeptor-Antagonist-Gen-Polymorphismus beim Ovarialkarzinom
Lycorine inhibits angiogenesis by docking to PDGFRα
Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis
COCO/DAND5 inhibits developmental and pathological ocular angiogenesis
SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression
Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury
Production of interleukin-1 receptor antagonist by human articular chondrocytes
CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth
Indirubin derivative E804 inhibits angiogenesis
Interleukin-1-receptor-antagonist inhibits migratory and invasive capacity of bladder cancer cells in vitro
CDK5RAP3 inhibits angiogenesis in gastric neuroendocrine carcinoma by modulating AKT/HIF-1α/VEGFA signaling
Interleukin-1 receptor antagonist inhibits metastatic potential by down-regulating CXCL12/CXCR4 signaling axis in colorectal cancer
Interleukin-1-Rezeptor-Antagonist-Gen-Polymorphismus beim Ovarialkarzinom
Lycorine inhibits angiogenesis by docking to PDGFRα
Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis
COCO/DAND5 inhibits developmental and pathological ocular angiogenesis
SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression
Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury